Abstract
The presence of adenosine receptors on cardiovascular tissues has previously been established on the basis of functional responses to adenosine and adenosine analogs. Specific functions attributed to each of the four adenosine receptor subtypes (A1, A2A, A2B, and A3) are discussed in detail below following a summary of the direct evidence for adenosine receptors in cardiovascular tissues based on the detection of receptor transcripts or protein.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Abbracchio MP, Ceruti S, Brambilla R, Barbieri D, Camurri A, Franceschi C, Giammarioli AM, Jacobson KA, Cattabeni F, Malorni W (1998) Adenosine A(3) receptors and viability of astrocytes. Drug Dev Res 45:379–386
Abebe W, Hussain T, Olanrewaju H, Mustafa SJ (1995) Role of nitric oxide in adenosine receptor mediated relaxation of porcine coronary artery. Am J Physiol 269:H1672–H1678
Armstrong S, Ganote CE (1995) In vitro ischaemic preconditioning of isolated rabbit cardiomyocytes: effects of selective adenosine receptor blockade and calphostin C. Cardiovascular Research 29:647–652
Armstrong SC, Hoover DB, Shivell LC, Ganote CE (1997) Preconditioning of isolated rabbit cardiomyocytes — no evident separation of induction, memory and protection. Journal of Molecular & Cellular Cardiology 29:2285–2298
Auchampach JA, Gross GJ (1993) Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Am J Physiol Heart Circ Physiol 264:H1327–H1336
Auchampach JA, Jin J, Wan TC, Caughey GH, Linden J (1997) Canine mast cell adenosine receptors: cloning and expression of the A3 receptors and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol 52:846–860
Barbieri D, Abbracchio MP, Salvioli S, Monti D, Cossarizza A, Ceruti S, Brambilla R, Cattabeni F, Jacobson KA, Franceschi C (1998) Apoptosis by 2-chloro-2′-deoxy- adenosine and 2-chloro-adenosine in human peripheral blood mononuclear cells. Neurochem Int 32:493–504
Bardenheuer H, Schrader J (1986) Supply-to-demand ratio for oxygen determines formation of adenosine by the heart. Am J Physiol 250:H173–80
Barnes CR, Mandell GL, Carper HT, Luong S, Sullivan GW (1995) Adenosine modulation of tumor necrosis factor-a-induced neutrophil activation. Biochem Pharmacol 50:1851–1857
Baukrowitz T, Schulte U, Oliver D, Herlitze S, Krauter T, Tucker SJ, Ruppersberg JP, Fakler B (1998) PIP2 and PIP as determinants for ATP inhibition of KATP channels [see comments]. Science 282:1141– 1144
Belardinelli L, Giles WR, West A (1988) Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol 405:615–633
Belardinelli L, Shryock JC, Ruble J, Monopoli A, Dionisotti S, Ongini E, Dennis DM, Baker SP (1996) Binding of the novel nonxanthine A2A adenosine receptor antagonist [3H]SCH58261 to coronary artery membranes. Circ Res 79:1153–1160
Belardinelli L, Shryock JC, Snowdy S, Zhang Y, Monopoli A, Lozza G, Ongini E, Olsson RA, Dennis DM (1998) The A2A adenosine receptor mediates coronary vasodilation. J Pharmacol Exp Ther 284:1066–1073
Bellardinelli L, Linden J, Berne RM (1989) The cardiac effects of adenosine. Prog Cardiovasc Dis 32:73–97
Claeys MJ, Yrints CJ, Bosmans JM, Conraads VM, Snoeck JP (1996) Aminophylline inhibits adaptation to ischaemia during angioplasty. Role of adenosine in ischaemic preconditioning [see comments]. Eur Heart J 17:539–544
Clemo HF, Belardinelli L (1986) Effect of adenosine on atrioventricular conduction. 2. Modulation of atrioventricular node transmission by adenosine in hypoxic isolated guinea pig hearts. Circ Res 59:437–446
Cleveland JCJ, Meldrum DR, Rowland RT, Banerjee A, Harken AH (1997) Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel. J Mol Cel Cardiol 29:175–182
Cleveland JCJ, Meldrum DR, Rowland RT, Sheridan BC, Banerjee A, Harken AH (1996) The obligate role of protein kinase C in mediating clinically accessible cardiac preconditioning. Surgery 120:345–352
Cohen MV, Yang XM, Downey JM (1997) Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon. Basic Res Cardiol 92:426–434
Cordeiro JM, Ferrier GR, Howlett SE (1995) Effects of adenosine in simulated ischemia and reperfusion in guinea pig ventricular myocytes. Am J Physiol 269:H121–H129
Cox BF, Greenland BD, Perrone MH, Merkel LA (1994) Ischaemia/reperfusion selectively attenuates coronary vasodilatation to an adenosine A2- but not to an A1- agonist in the dog. Br J Pharmacol 111:1233–1239
Darvish A, Metting PJ (1993) Purification and regulation of an AMP-specific cytosolic 5′-nucleotidase from dog heart. Am J Physiol 264:H1528–H1534
Dawicki DD, Chatterjee D, Wyche J, Rounds S (1997) Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol 273:L485–L494
Decking UK, Schlieper G, Kroll K, Schrader J (1997) Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release. Circ Res 81:154–164
Decking UKM, Schrader J (1998) Role of adenosine kinase and AMP deminase in the regulation of cardaic purine release. Drug Dev Res 45:295–303
Deussen A, Borst M, Kroll K, Schrader J (1988) Formation of S-adenosylhomocysteine in the heart. 2. A sensitive index for regional myocardial underperfusion. Circ Res 63:250–261
Deussen A, Moser G, Schrader J (1986) Contribution of coronary endothelial cells to cardiac adenosine production. Pflugers Arch 406:608–614
Deutsch E, Berger M, Kussmaul WG, Hirshfeld JWJ, Herrmann HC, Laskey WK (1990) Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features [see comments]. Circ 82:2044–2051
Dixon AK, Gubitz AK, Sirinathsinghji DJ, Richardson PJ, Freeman TC (1996) Tissue distribution of adenosine receptor mRNAs in the rat. Br J Pharmacol 118:1461–1468
Dobson JG, Fenton RA (1998) Cardiac physiology of adenosine. In: Burnstock G, Dobson JGJ, Liang BT, Linden J (eds) Cardovascular biology of purines. Kluwer, Dordrecht, p 21
Dorschner H, Brekardin E, Uhde I, Schwanstecher C, Schwanstecher M (1999) Stoichiometry of sulfonylure a-induced ATP-sensitive potassium channel closure. Mol Pharmaco155:1060–1066
Dougherty C, Barucha J, Schofield PR, Jacobson KA, Liang BT (1998) Cardiac myocytes rendered ischemia resistant by expressing the human adenosine Al or A3 receptor. FASEB J 12:1785–1792
Drury AN, Szent-Gyorgyi A (1929) The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J Physiol (London) 68:213–237
Dunckcr DJ, Stubenitsky R, Verdouw PD (1998) Role of adenosine in the regulation of coronary blood flow in swine at rest and during treadmill exercise. Am J Physiol 275:H1663–H1772
Duncker DJ, Van Zon NS, Ishibashi Y, Bache RJ (1996) Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. J Clin Invest 97:996–1009
Ely SW, Mentzer RMJ, Lasley RD, Lee BK, Berne RM (1985) Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine. J Thorac Cardiovasc Surg 90:549–556
Ethier MF, Chander V, Dobson JGJ (1993) Adenosine stimulates proliferation of human endothelial cells in culture. Am J Physiol 265:H131–H138
Evoniuk G, von Borstel RW, Wurtman RJ (1987) Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline. J Pharmacol Exp Ther 240:428–432
Felix SB, Stangl V, Frank TM, Harms C, Berndt T, Kastner R, Baumann G (1997) Release of a stable cardiodepressant mediator after myocardial ischaemia during reperfusion. Cardiovasc Res 35:68–79
Fredholm BB, Jacobson KA, Jonzon B, Kirk KL, Li YO, Daly JW (1987) Evidence that a novel 8- phenyl-substituted xanthine derivative is a cardioselective adenosine receptor antagonist in vivo. J Cardiovasc Pharmacol 9:396–400
Froldi G, Belardinelli L (1990) Species-dependent effects of adenosine on heart rate and atrioventricular nodal conduction. Mechanism and physiological implications. Circ Res 67:960–978
Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D’Alonzo AJ, Lodge NJ, Smith MA, Grover GJ (1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP- sensitive K+ channels. Possible mechanism of cardioprotection. Circ Res 81:1072–1082
Gauthier NS, Morrison RR, Byford AM, Jones R, Headrick JP, Matherne GP (1998) Functional genomics of transgenic overexpression of A(1) adenosine receptors in the heart. Drug Dev Res 45:402–409
Giannella E, Mochmann HC, Levi R (1997) Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation. Circ Res 81:415–422
Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL (1994) Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94:1621–1628
Grigoriev SM, Skarga YY, Mironova GD, Marinov BS (1999) Regulation of mitochondrial K-ATP channel by redox agents. Biochim Biophys Acta 1410:91–96
Hannon JP, Pfannkuche HJ, Fozard JR (1995) A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol 115:945–952
Harden FA, Harrison GJ, Headrick J, Jordan LR, Willis RJ (1996) A biphasic response to adenosine in the coronary vasculature of the K(+)-arrested perfused rat heart. Eur J Pharmacol 307:49–53
Harrison GJ, Willis RJ, Headrick JP (1998) Extracellular adenosine levels and cellular energy metabolism in isochemically preconditioned rat heart. Cardiovasc Res 40:74–87
Hashimi MW, Thornton JD, Downey JM, Cohen MV (1998) Loss of myocardial protection from ischemic preconditioning following chronic exposure to R(−)-N6-(2-phenylisopropyl) adenosine is related to defect at the adenosine A1 receptor. Mol Cell Biochem 186:19–25
Hashimura K, Kijima Y, Matsu-ura Y, Ueda T, Kato Y, Mori I, Minamino T, Kitakaze M, Hori M (1997) Effect of theophylline on adaptation of the heart to myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with stable angina pectoris. Am J Cardiol 79:475–477
Headrick JP (1996) Ischemic preconditioning: bioenergetic and metabolic changes and the role of endogenous adenosine. J Mol Cell Cardiol 28:1227–1240
Headrick JP, Matherne GP, Berne RM (1992) Myocardial adenosine formation during hypoxia: effects of ecto-5′-nucleotidase inhibition. J Mol Cell Cardiol 24:295–303
Hill RJ, Oleynek JJ, Magee W, Knight DR, Tracey WR (1998) Relative importance of adenosine A1 and A3 receptors in mediating physiological or pharmacological protection from ischemic myocardial injury in the rabbit heart. J Mol Cell Cardiol 30:579–585
Hofman PL, Hiatt K, Yoder MC, Rivkees SA (1997) A1 adenosine receptors potently regulate heart rate in mammalian embryos. Am J Physiol 273:R1374–R1380
Hu H, Sato T, Seharaseyon J, Liu YG, Johns DC, O’Rourke B, Marban E (1999) Pharmacological and histochemical distinctions between molecularly defined sarcolemmal K-ATP channels and native cardiac mitochondrial K-ATP channels. Mol Pharmacol 55:1000–1005
Hu K, Li GR, Nattel S (1999) Adenosine-induced activation of ATP-sensitive K+ channels in excised membrane patches is mediated by PKC. Am J Physiol 276:H488–H495
Huang CH, Kim SJ, Ghaleh B, Kudej RK, Shen YT, Bishop SP, Vatner SF (1999) An adenosine agonist and preconditioning shift the distribution of myocardial blood flow in conscious pigs. Am J Physiol 276:H368–H375
Ikonomidis JS, Shirai T, Weisel RD, Derylo B, Rao V, Whiteside CI, Mickle DA, Li RK (1997) Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am J Physiol 272:H1220–H1230
Iliodromitis EK, Miki T, Liu Gs, Downey JM, Cohen MV, Kremastinos DT (1998) The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5′-nucleotidase important? J Mol Cell Cardiol 30:2201–2211
Jacobson KA, Moro S, Kim YC, Li AH (1998) A(3) adenosin e receptors: protective vs. damaging effects identified using novel agonists and antagonists. Drug Dev Res 45:113–124
Jin X, Shepherd RK, Duling BR, Linden J (1997) Inosine binds to A3 adenosine receptors and stimulates mast cell degranulation. J Clin Invest 100:2849–2857
Karczewski P, Hendrischke T, Wolf WP, Morano I, Bartel S, Schrader J (1998) Phosphorylation of phospholamban correlates with relaxation of coronary artery induced by nitric oxide, adenosine, and prostacyclin in the pig. J Cell Biochem 70:49–59
Karmazyn M, Cook MA (1992) Adenosine A1 receptor activation attenuates cardiac injury produced by hydrogen peroxide. Circ Res 71:1101–1110
Karoon P, Rubino A, Burnstock G (1995) Enhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX)-treated rats. Br J Pharmacol 116:1918–1922
Kitakaze M, Minamino T, Node K, Komamura K, Inoue M, Hori M, Kamada T (1996) Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes. J Mol Cell Cardiol 28:1945–1955
Kroll K, Decking UK, Dreikorn K, Schrader J (1993) Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ Res 73:846–856
Kurachi Y, Nakajima T, Sugimoto T (1986) On the mechanism of activation of muscarinic potassium channels by adenosine in isolated atrial cells: involvement of GTP-binding proteins. Pflugers Arch 407:264–274
Kusachi S, Thompson RD, Olsson RA (1983) Ligand selectivity of dog coronary adenosine receptor resembles that of adenylate cyclase stimulatory (Ra) receptors. J Pharmacol Exp Ther 227:316–321
Lasley RD, Noble MA, Konyn PJ, Mentzer RM, Jr. (1995) Different effects of an adenosine A1 analogue and ischemic preconditioning in isolated rabbit hearts. Ann Thorac Surg 60:1698–1703
Lee AE, Wilcox K, Jacobson KA, Dichter M, Liang BT (1998) Adenosine receptor subtypes and cardioprotection. Drug Dev Res 45:394–401
Lee HT, Thompson CI, Hernandez A, Lewy JL, Belloni FL (1993a) Cardiac desensitization to adenosine analogues after prolonged R-PIA infusion in vivo. Am J Physiol 265:H1916–H1927
Lee HT, Thompson CI, Linden J, Belloni FL (1993b) Differential sensitization of cardiac actions of adenosine in rats after chronic theophylline treatment. Am J Physiol 264:H1634–H1643
Li JM, Fenton RA, Cutler BS, Dobson JGJ (1995) Adenosine enhances nitric oxide production by vascular endothelial cells. Am J Physiol 269:C519–C523
Liang BT (1997) Protein kinase C-mediated preconditioning of cardiac myocytes: role of adenosine receptor and KATP channel. Am J Physiol 273:H847–H853
Liang BT (1998) Protein kinase C-dependent activation of KATP channel enhances adenosine-induced cardioprotection. Biochem J 336:337–343
Liang BT, Jacobson KA (1998) A physiological role of the adenosine A3 receptor: sustained cardioprotection. Proc Natl Acad Sci USA 95:6995–6999
Libert F, Schiffmann SN, Lefort A, Parmentier M, Gérard C, Dumont JE, Vanderhaeghen J-J, Vassart G (1991) The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J 10:1677–1682
Linden J (1991) Structure and function of the A1 adenosine receptor. FASEB J 5:2668–2676
Linden J (1994) Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:298–306
Linden J, Hollen CE, Patel A (1990) The mechanism by which adenosine and cholinergic agents reduce contractility in rat myocardium: correlation with cyclic adenosine monophosphate and receptor densities. Circ Res 56:728–735
Linden J, Jacobson KA (1998) Molecular biology and pharmacology of recombinant human adenosine receptors. In: Burnstock G, Dobson JG Jr, Liang BT, Linden J (eds) Cardiovascular biology of purines. Kluwer, Dordrecht, p 1
Linden J, Patel A, Sadek S (1985) [125I]Aminobenzyladenosine, a new radioligand with improved specific binding to adenosine receptors in heart. Circ Res 56:279–284
Linden J, Thai T, Figler H, Robeva AS (1999) Characterization of human A2B adenosine receptors: radioligand binding, Western blotting and coupling to Gq in HEK-293 and HMC-1 mast cells. Mol Pharmacol 56:705–713
Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM (1991) Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circ 84:350–356
Liu Y, Sato T, O’Rourke B, Marban E (1998) Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circ 97:2463–2469
Lloyd HG, Schrader J (1993) Adenosine metabolism in the guinea pig heart: the role of cytosolic S-adenosyl-L-homocysteine hydrolase, 5′-nucleotidase and adenosine kinase. Eur Heart J 14 [Suppl I]:27– 33
Louttit JB, Hunt AAE, Maxwell MP, Drew GM (1999) The time course of cardioprotection induced by GR79236, a selective adenosine A(1)-recept or agonist, in myocardial ischaemia-reperfusion injury in the pig. J Cardiovasc Pharmacol 33:285–291
Lozza G, Conti A, Ongini E, Monopoli A (1997) Cardioprotective effects of adenosine A1 and A2A receptor agonists in the isolated rat heart. Pharmacol Res 35:57–64
Luthin DR, Olsson RA, Thompson RD, Sawmiller DR, Linden J (1995) Characterization of two affinity states of adenosine A2A receptors with a new radioligand, 2-[2-(4-amino-3-[125I]iodophenyl)ethylamino]adenosine. Mol Pharmacol 47:307–313
Maczewski M, Beresewicz A (1998) The role of adenosine and ATP-sensitive potassium channels in the protection afforded by ischemic preconditioning against the post-ischemic endothelial dysfunction in guinea-pig hearts. J Mol Cell Cardiol 30:1735–1747
Martin PL (1992) Evidence that adenosine receptors in the dog left atrium are not of the typical A1 or A2 adenosine receptor subtypes. Eur J Pharmacol 214:199–205
Martin PL, Ueeda M, Olsson RA (1993) 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig. J Pharmacol Exp Ther 265:248–253
Martin PL, Wysocki RJ, Barrett RJ, May JM, Linden J (1996) Characterization of 8-(N- methylisopropyl)amino-N6-(5′-endohydroxy-endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors. J Pharmacol Exp Ther 276:490–499
Matherne GP, Byford AM, Gilrain JT, Dalkin AC (1996) Changes in myocardial A1 adenosine receptor and message levels during fetal development and postnatal maturation. Biol Neonate 70:199–205
Matherne GP, Linden J, Byford AM, Gauthier NS, Headrick JP (1997) Transgenic A(1) adenosine receptor overexpression increases myocardial resistance to ischemia. Proc Natl Acad Sci USA 94:6541–6546
Mathot RA, Cleton A, Soudijn W, Ijzerman AP, Danhof M (1995) Pharmacokinetic modelling of the haemodynamic effects of the A2A adenosine receptor agonist CGS 21680C in conscious normotensive rats. Br J Pharmacol 114:761–768
McKinley JB, Dahlman D, MacLeod KM (1990) The interaction of adenosine analogues with cAMP-generating and cAMP-independent positive inotropic agents in rabbit left atrium. Naunyn-Schmiedebergs Arch Pharmacol 342:605–612
Meester BJ, Shankley NP, Welsh NJ, Wood J, Meijler FL, Black JW (1998) Pharmacological classification of adenosine receptors in the sinoatrial and atrioventricular nodes of the guinea-pig. Br J Pharmacol 124:685–692
Meininger CJ, Schelling ME, Granger HJ (1988) Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 255:H554–H562
Meng F, Xie G, Chalmers D, Morgan C, Watson SJ Jr, Akil H (1994) Cloning and expression of the A2A adenosine receptor from guinea pig brain. Neurochem Res 19:613–621
Meyerhof W, Müller-Brechlin R, Richter D (1991) Molecular cloning of a novel putative G-protein coupled recept or expressed during rat spermiogenesis. Febs Lett 284:155–160
Minamino T, Kitakaze M, Komamura K, Node K, Takeda H, Inoue M, Hori M, Kamada T (1995) Activation of protein kinase C increases adenosine production in the hypoxic canine coronary artery through the extracellular pathway. Arterioscler Thromb Vase Biol 15:2298–2304
Miura T, Kawamura S, Goto M, Sakamoto J, Tsuchida A, Matsuzaki M, Shimamoto K (1998) Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes. Cardiovasc Res 37:700–709
Miura T, Suzuki K, Shimamoto K, Iimura O (1996) Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning. Basic Res Cardiol 91:425–432
Miura T, Tsuchida A (1999) Adenosine and preconditioning revisited [Review]. Clin Exp Pharmacol Physiol 26:92–99
Miyawaki H, Ashraf M (1997) CA2+ as a mediator of ischemic preconditioning. Circ Res 80:790–799
Mizumura T, Auchampach JA, Linden J, Bruns RF, Gross GJ (1996) PD 81, 723, an allosteric enhancer of the Al adenosine receptor, lowers the threshold for ischemic preconditioning in dogs. Circ Res 79:415–423
Monopoli A, Casati C, Lozza G, Forlani A, Ongini E (1998) Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat. J Pharmacol Exp Ther 285:9–15
Mudumbi RV, Montamat SC, Bruns RF, Vestal RE (1993) Cardiac functional responses to adenosine by PD 81723, an allosteric enhancer of the adenosine A1 receptor. Am J Physiol 264:H1017–H1022
Munch G, Kurz T, Urlbauer T, Seyfarth M, Richardt G (1996) Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia. Br J Pharmacol 118:1855–1861
Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circ 74:1124–1136
Musser B, Morgan ME, Leid M, Murray TF, Linden J, Vestal RE (1993) Species comparison of adenosine and β-adrenoceptors in mammalian atrial and ventricular myocardium. Eur J Pharmacol 246:105–111
Nees S, Herzog V, Becker BF, Bock M, Des RC, Gerlach E (1985) The coronary endothelium: a highly active metabolic barrier for adenosine. Basic Res Cardiol 80:515–529
Newby AC (1984) Adenosine and the concept of “retaliatory metabolites”. Trends Biol Sci 9:42–44
Niwa M, Hara A, Kanamori Y, Matsuno H, Kozawa O, Yoshimi N, Mori H, Uematsu T (1999) Inhibition of tumor necrosis factor-alpha induced neutrophil apoptosis by cyclicAMP: involvement of caspase cascade. Eur J Pharmacol 371:59–67
Norton GR, Woodiwiss AJ, McGinn RJ, Lorbar M, Chung ES, Honeyman TW, Fenton RA, Dobson JGJ, Meyer TE (1999) Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2A receptor activation in rat heart. Am J Physiol 276:H341-H349
Ogata T, Schubert P (1996) Programmed cell death in rat microglia is controlled by extracellular adenosine. Neurosci Lett 218:91–94
Oguchi T, Furukawa Y, Sawaki S, Kasama M, Chiba S (1995) Are negative chronotropic and inotropic responses to adenosine differentiated at the receptor or postreceptor levels in isolated dog hearts? J Pharmacol Exp Ther 272:838–844
Parenteau GL, Clark RE (1991) Prevention of ischemia-reperfusion injury by the allergy drug lodoxamide tromethamine. Ann Thorac Surg 52:832–838
Park KH, Rubin LE, Gross SS, Levi R (1992) Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res 71:992–1001
Parkinson FE, Clanachan AS (1991) Adenosine receptors and nucleoside transport sites in cardiac cells. Br J Pharmacol 104:399–405
Peterfreund RA, MacCollin M, Gusella J, Fink JS (1996) Characterization and expression of the human A2A adenosine receptor gene. J Neurochem 66:362–368
Phillis JW, Song D, O’Regan MH (1998) The role of adenosine in rat coronary flow regulation during respiratory and metabolic acidosis. Eur J Pharmacol 356:199–206
Pisarenko OI, Tskitishvily OV, Studneva IM, Serebryakova LI, Timoshin AA, Ruuge EK (1997) Metabolic and antioxidant effects of R(+/−)-N6-(2-phenylisopropyl)-adenosine following regional ischemia and reperfusion in canine myocardium. Biochim Biophys Acta 1361:295–303
Przyklenk K, Hata K, Zhao L, Kloner RA, Elliott GT (1997) Disparate effects of preconditioning and MLA on 5′-NT and adenosine levels during coronary occlusion. Am J Physiol 273:H945–H951
Raatikainen MJ, Peuhkurinen KJ, Hassinen IE (1994) Contribution of endothelium and cardiomyocytes to hypoxia-induced adenosine release. J Mol Cell Cardiol 26:1069–1080
Reeves JJ, Jones CA, Sheehan MJ, Vardey CJ, Whelan CJ (1997) Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflamm Research 46:180–184
Reimer KA, Murry CE, Yamasawa I, Hill ML, Jennings RB (1986) Four brief periods of myocardial ischemia cause no cumulative ATP loss or necrosis. Am J Physiol 251:H1306–H1315
Reppert SM, Weaver DR, Stehle JH, Rivkees SA (1991) Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord. Mol Endocrinol 5:1037–1048
Rice PJ, Armstrong SC, Ganote CE (1996) Concentration-response relationships for adenosine agonists during preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol 28:1355–1365
Sanae F, Ohmae S, Kurita M, Sawanishi H, Takagi K, Miyamoto K (1995) Structureactivity relationships of alkylxanthines: alkyl chain elongation at the N1- or N7-position decreases cardiotonic activity in the isolated guinea pig heart. Jpn J Pharmacol 69:75–82
Sato T, O’Rourke B, Marban E (1998) Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. Circ Res 83:110–114
Schlack W, Schafer M, Uebing A, Schafer S, Borchard U, Thamer V (1993) Adenosine A2-receptor activation at reperfusion reduces infarct size and improves myocardial wall function in dog heart. J Cardiovasc Pharmacol 22:89–96
Schreieck J, Richardt G (1999) Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart. J Mol Cell Cardiol 31:123–134
Schütz W, Schrader J, Gerlach E (1981) Different sites of adenosine formation in the heart. Am J Physiol 240:H963-H970
Shepherd RK, Duling BR (1996) Inosine-induced vasoconstriction is mediated by histamine and thromboxane derived from mast cells. Am J Physiol 270:H560–H566
Shepherd RK, Linden J, Duling BR (1996) Adenosine-induced vasoconstriction in vivo — role of the mast cell and A(3) adenosine receptor. Circ Res 78:627–634
Shiki K, Hearse DJ (1987) Preconditioning of ischemic myocardium: reperfusioninduced arrhythmias. Am J Physiol 253:H1470–H1476
Shneyvays V, Nawrath H, Jacobson KA, Shainberg A (1998) Induction of apoptosis in cardiac myocytes by an A3 adenosine receptor agonist. Exp Cell Res 243:383–397
Shryock JC, Belardinelli L (1997) Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology [Review]. Am J Cardiol 79:2–10
Shryock JC, Snowdy S, Baraldi PG, Cacciari B, Spalluto G, Monopoli A, Ongini E, Baker SP, Belardinelli L (1998) A(2A)-Adenosine receptor reserve for coronary vasodilation. Circ 98:711–718
Shyng SL, Nichols CG (1998) Membrane phospholipid control of nucleotide sensitivity of KATP channels [see comments]. Science 282:1138–1141
Slezak J, Tribulova N, Pristacova J, Uhrik B, Thomas T, Khaper N, Kaul N, Singal PK (1995) Hydrogen peroxide changes in ischemic and reperfused heart. Cytochemistry and biochemical and X-ray microanalysis. Am J Pathol 147:772–781
Smits GJ, McVey M, Cox BF, Perrone MH, Clark KL (1998) Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction. J Pharmacol Exp Ther 286:611–618
Smits P, Lenders JWM, Willemsen JJ, Thien T (1991) Adenosine attenuates the response to sympathetic stimuli in humans. Hypertension 18:216–223
Smolenski RT, Suitters A, Yacoub MH (1992) Adenine nucleotide catabolism and adenosine formation in isolated human cardiomyocytes [errata in J Mol Cell Cardiol 1993, 25(7):887 and 1993, 25:1381]. J Mol Cell Cardiol 24:91–96
Snowdy S, Liang HX, Blackburn B, Lum R, Nelson M, Wang L, Pfister J, Sharma BP, Wolff A, Belardinelli L (1999) A comparison of an A(1) adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guineapig. Br J Pharmacol 126:137–146
Sommerschild HT, Grund F, Offstad J, Jynge P, Ilebekk A, Kirkeboen KA (1997) Importance of endogenous adenosine during ischemia and reperfusion in neonatal porcine hearts. Circ 96:3094–3103
Stehle JH, Rivkees SA, Lee JJ, Weaver DR, Deeds JD, Reppert SM (1992) Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype. Mol Endo 6(3):384–393
Stella L, Berrino L, Maione S, de Novellis V, Rossi F (1993) Cardiovascular effects of adenosine and its analogs in anaesthetized rats. Life Sci 53:755–763
Stella L, de Novellis V, Marabese I, Berrino L, Maione S, Filippelli A, Rossi F (1998) The role of A3 adenosine receptors in central regulation of arterial blood pressure. Br J Pharmacol 125:437–440
Stepp DW, Van Bibber R, Kroll K, Feigl EO (1996) Quantitative relation between interstitial adenosine concentration and coronary blood flow. Circ Res 79:601–610
Strickler J, Jacobson KA, Liang BT (1996) Direct preconditioning of cultured chick ventricular myocytes novel functions of cardiac adenosine a(2a) and a(3) receptors. J Clin Invest 98:1773–1779
Sullivan GW, Linden J (1998) Role of A2A adenosine receptors in inflammation. Drug Dev Res 45:103–112
Szewczyk A, Marban E (1999) Mitochondria: a new target for K+ channel openers? Trends Pharmacol Sci 20:157–161
Taggart PI, Sutton PMI, Oliver RM, Swanton RH (1993) Ischemic preconditioning may activate potassium channels in humans? Circ 88 [Suppl I]:69
Takagi H, King GL, Ferrara N, Aiello LP (1996b) Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 37:1311–1321
Takagi H, King GL, Robinson GS, Ferrara N, Aiello LP (1996a) Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci 37:2165–2176
Tanaka M, Ito H, Adachi S, Akimoto H, Nishikawa T, Kasajima T, Marumo F, Hiroe M (1994) Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res 75:426–433
Tang XL, Wang HX, Cho CH, Wong TM (1998) Reduced responsiveness of [Ca2+]i to adenosine A1- and A2-receptor stimulation in the isoproterenol-stimulated ventricular myocytes of spontaneously hypertensive rats. J Cardiovasc Pharmacol 31:493–498
Thomas GP, Sims SM, Cook MA, Karmazyn M (1998) Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. J Pharmacol Exp Ther 286:1208–1214
Tofovic SP, Branch KR, Oliver RD, Magee WD, Jackson EK (1991) Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850–860
Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Polisca P, Chiariello L, Gioffre PA (1996) Effects of A1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty [see comments]. Eur Heart J 17:846–853
Tomai F, Danesi A, Ghini AS, Crea F, Perino M, Gaspardone A, Ruggeri G, Chiariello L, Gioffre PA (1999) Effects of K-ATP channel blockade by glibenclamide on the warm-up phenomenon. Eur Heart J 20:196–202
Tracey WR, Magee W, Masamune H, Kennedy SP, Knight DR, Buchholz RA, Hill RJ (1997) Selective adenosine a(3) receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovas Res 33:410–415
Tracey WR, Magee W, Masamune H, Oleynek JJ, Hill RJ (1998) Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5′-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation. Cardiovas Res 40:138–145
Trautwein W, Hescheler J (1990) Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu Rev Physiol 52:257–274
Tseng CJ, Biaggioni I, Appalsamy M, Robertson D (1988) Purinergic receptors in the brainstem mediate hypotension and bradycardia. Hypertension 11:191–197
Walker BA, Rocchini C, Boone RH, Ip S, Jacobson MA (1997) Adenosine A2A receptor activation delays apoptosis in human neutrophils. J Immunol 158:2926–2931
Wang D, Belardinelli L (1994) Mechanism of the negative inotropic effect of adenosine in guinea pig atrial myocytes. Am J Physiol 267:H2420–H2429
Wang D, Shryock JC, Belardinelli L (1996a) Cellular basis for the negative dromotropic effect of adenosine on rabbit single atrioventricular nodal cells. Circ Res 78:697–706
Wang J, Drake L, Sajjadi F, Firestein GS, Mullane KM, Bullough DA (1997) Dual activation of adenosine A1 and A3 receptors mediates preconditioning of isolated cardiac myocytes. Eur J Pharmacol 320:241–248
Wang P, Downey JM, Cohen MV (1996b) Mast cell degranulation does not contribute to ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 91:458–467
Wang YG, Ashraf M (1999) Role of protein kinase C in mitochondrial K-ATP channelmediated protection against Ca2+ overload injury in rat myocardium. Circ Res 84:1156–1165
Webb RL, McNeal RBJ, Barclay BW, Yasay GD (1990) Hemodynamic effects of adenosine agonists in the conscious spontaneously hypertensive rat. J Pharmacol Exp Ther 254:1090–1099
Wickman K, Nemec J, Gendler SJ, Clapham DE (1998) Abnormal heart rate regulation in GIRK4 knockout mice. Neuron 20:103–114
Winter CB, Cleveland JC, Butler KL, Bensard DB, Mitchell MB, Harken AH, Banerjee A (1997) Facilitative interactions between noradrenergic and purinergic signaling during preconditioning of the rat heart. J Mol Cell Cardiol 29:163–173
Wu S-N, Linden J, Visentin S, Boykin M, Belardinelli L (1989) Enhanced sensitivity of heart cells to adenosine and up-regulation of receptor number after treatment of guinea pigs with theophylline. Circ Res 65:1066–1077
Xuan YT, Tang XL, Banerjee S, Takano H, Li RCX, Han H, Qiu YM, Li JJ, Bolli R (1999) Nuclear factor-kappa B plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res 84:1095–1109
Zhang J, Belardinelli L, Jacobson KA, Otero DH, Baker SP (1997) Persistent activation by and receptor reserve for an irreversible A1-adenosine receptor agonist in DDTl MF-2 cells and in guinea pig heart. Mol Pharmacol 52:491–498
Zhao Z, Francis CE, Ravid K (1997) An A3-subtype adenosine receptor is highly expressed in rat vascular smooth muscle cells: its role in attenuating adenosineinduced increase in cAMP. Microvasc Res 54:243–252
Zhou QY, Li C, Olah ME, Stiles GL, Civelli O (1992) Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor. Proc Natl Acad Sci USA 89:7432–7436
Zhou XB, Zhai XL, Ashraf M (1996) Preconditioning of bovine endothelial cells — the protective effect is mediated by an adenosine A2 receptor through a protein kinase C signaling pathway. Circ Res 78:73–81
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Broad, R., Linden, J. (2001). P1 Receptors in the Cardiovascular System. In: Abbracchio, M.P., Williams, M. (eds) Purinergic and Pyrimidinergic Signalling II. Handbook of Experimental Pharmacology, vol 151 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56921-0_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-56921-0_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-67848-9
Online ISBN: 978-3-642-56921-0
eBook Packages: Springer Book Archive